To determine whether rotavirus infection in newborn babies conferred immunity to postneonatal rotavirus infection, we studied 81 babies at birth and kept them under clinical and serologic study for three years. During the first 14 days of life, 44 of the infants excreted rotavirus, and 37 did not. Fifty-five per cent of those with neonatal infection and 54 per cent of those without it had rotavirus infection during the next three years. Symptoms associated with postneonatal rotavirus infection were significantly less frequent and less severe in the infants who had had neonatal infection (P = 0.003) than in those who had not. Thirty-eight per cent of the former group (9 of 24 infants) had symptoms of mild (3 infants) or moderate (6) severity during the first postneonatal infection. In contrast, 85 per cent of the latter group (17 of 20 infants) had mild (3), moderate (6), or severe (8) symptoms. We conclude that neonatal rotavirus infection does not confer immunity against reinfection but does protect against the development of clinically severe disease during reinfection.
This article has been cited by other articles:
Dennehy, P. H.
(2008). Rotavirus Vaccines: an Overview. Clin. Microbiol. Rev.
21: 198-208
[Abstract][Full Text]
Ray, P., Sharma, S., Agarwal, R. K., Longmei, K., Gentsch, J. R., Paul, V. K., Glass, R. I., Bhan, M. K.
(2007). First Detection of G12 Rotaviruses in Newborns with Neonatal Rotavirus Infection at All India Institute of Medical Sciences, New Delhi, India. J. Clin. Microbiol.
45: 3824-3827
[Abstract][Full Text]
Ruiz-Palacios, G. M., Guerrero, M. L., Bautista-Marquez, A., Ortega-Gallegos, H., Tuz-Dzib, F., Reyes-Gonzalez, L., Rosales-Pedraza, G., Martinez-Lopez, J., Castanon-Acosta, E., Cervantes, Y., Costa-Clemens, S., DeVos, B.
(2007). Dose Response and Efficacy of a Live, Attenuated Human Rotavirus Vaccine in Mexican Infants. Pediatrics
120: e253-e261
[Abstract][Full Text]
Committee on Infectious Diseases,
(2007). Prevention of Rotavirus Disease: Guidelines for Use of Rotavirus Vaccine. Pediatrics
119: 171-182
[Abstract][Full Text]
VanCott, J. L., Prada, A. E., McNeal, M. M., Stone, S. C., Basu, M., Huffer, B. Jr., Smiley, K. L., Shao, M., Bean, J. A., Clements, J. D., Choi, A. H.-C., Ward, R. L.
(2006). Mice Develop Effective but Delayed Protective Immune Responses When Immunized as Neonates either Intranasally with Nonliving VP6/LT(R192G) or Orally with Live Rhesus Rotavirus Vaccine Candidates.. J. Virol.
80: 4949-4961
[Abstract][Full Text]
Westerman, L. E., McClure, H. M., Jiang, B., Almond, J. W., Glass, R. I.
(2005). Serum IgG mediates mucosal immunity against rotavirus infection. Proc. Natl. Acad. Sci. USA
102: 7268-7273
[Abstract][Full Text]
Xu, J., Dennehy, P., Keyserling, H., Westerman, L. E., Wang, Y., Holman, R. C., Gentsch, J. R., Glass, R. I., Jiang, B.
(2005). Serum Antibody Responses in Children with Rotavirus Diarrhea Can Serve as Proxy for Protection. CVI
12: 273-279
[Abstract][Full Text]
Ray, P. G., Kelkar, S. D.
(2004). Prevalence of Neutralizing Antibodies against Different Rotavirus Serotypes in Children with Severe Rotavirus-Induced Diarrhea and Their Mothers. CVI
11: 186-194
[Abstract][Full Text]
Jiang, B, Snipes-Magaldi, L., Dennehy, P., Keyserling, H., Holman, R. C., Bresee, J., Gentsch, J., Glass, R. I.
(2003). Cytokines as Mediators for or Effectors against Rotavirus Disease in Children. CVI
10: 995-1001
[Abstract][Full Text]
Cunliffe, N. A., Rogerson, S., Dove, W., Thindwa, B. D. M., Greensill, J., Kirkwood, C. D., Broadhead, R. L., Hart, C. A.
(2002). Detection and Characterization of Rotaviruses in Hospitalized Neonates in Blantyre, Malawi. J. Clin. Microbiol.
40: 1534-1537
[Abstract][Full Text]
Fischer, T. K., Steinsland, H., Mølbak, K., Ca, R., Gentsch, J. R., Valentiner-Branth, P., Aaby, P., Sommerfelt, H.
(2000). Genotype Profiles of Rotavirus Strains from Children in a Suburban Community in Guinea-Bissau, Western Africa. J. Clin. Microbiol.
38: 264-267
[Abstract][Full Text]
Crawford, S. E., Estes, M. K., Ciarlet, M., Barone, C., O'Neal, C. M., Cohen, J., Conner, M. E.
(1999). Heterotypic Protection and Induction of a Broad Heterotypic Neutralization Response by Rotavirus-Like Particles. J. Virol.
73: 4813-4822
[Abstract][Full Text]
Hodgins, D. C., Kang, S. Y., deArriba, L., Parreno, V., Ward, L. A., Yuan, L., To, T., Saif, L. J.
(1999). Effects of Maternal Antibodies on Protection and Development of Antibody Responses to Human Rotavirus in Gnotobiotic Pigs. J. Virol.
73: 186-197
[Abstract][Full Text]
Committee on Infectious Diseases,
(1998). Prevention of Rotavirus Disease: Guidelines for Use of Rotavirus Vaccine. Pediatrics
102: 1483-1491
[Abstract][Full Text]
Coulson, B. S.
(1998). Longitudinal Studies of Neutralizing Antibody Responses to Rotavirus in Stools and Sera of Children following Severe Rotavirus Gastroenteritis. CVI
5: 897-901
[Abstract][Full Text]
Ramachandran, M., Vij, A., Kumar, R., Das, B. K., Gentsch, J. R., Bhan, M. K., Glass, R. I.
(1998). Lack of Maternal Antibodies to P Serotypes May Predispose Neonates to Infections with Unusual Rotavirus Strains. CVI
5: 527-530
[Abstract][Full Text]
Perez-Schael, I., Guntinas, M. J., Perez, M., Pagone, V., Rojas, A. M., Gonzalez, R., Cunto, W., Hoshino, Y., Kapikian, A. Z.
(1997). Efficacy of the Rhesus Rotavirus-Based Quadrivalent Vaccine in Infants and Young Children in Venezuela. NEJM
337: 1181-1187
[Abstract][Full Text]
Velazquez, F. R., Matson, D. O., Calva, J. J., Guerrero, M. L., Morrow, A. L., Carter-Campbell, S., Glass, R. I., Estes, M. K., Pickering, L. K., Ruiz-Palacios, G. M.
(1996). Rotavirus Infection in Infants as Protection against Subsequent Infections. NEJM
335: 1022-1028
[Abstract][Full Text]
Glass, R., Gentsch, J, Smith, J.
(1994). Rotavirus vaccines: success by reassortment?. Science
265: 1389-1391
Previous
